U.S. Automated And Closed Cell Therapy Processing Systems Market Size & Outlook
U.S. automated and closed cell therapy processing systems market, 2018-2030 (US$M)
Related Markets
U.S. automated and closed cell therapy processing systems market highlights
- The U.S. automated and closed cell therapy processing systems market generated a revenue of USD 651.7 million in 2024 and is expected to reach USD 1,876.7 million by 2030.
- The U.S. market is expected to grow at a CAGR of 19.4% from 2025 to 2030.
- In terms of segment, pre-commercial/ r&d scale was the largest revenue generating scale in 2024.
- Commercial Scale is the most lucrative scale segment registering the fastest growth during the forecast period.
Automated and closed cell therapy processing systems market data book summary
| Market revenue in 2024 | USD 651.7 million |
| Market revenue in 2030 | USD 1,876.7 million |
| Growth rate | 19.4% (CAGR from 2025 to 2030) |
| Largest segment | Pre-commercial/ r&d scale |
| Fastest growing segment | Commercial Scale |
| Historical data | 2018 - 2023 |
| Base year | 2024 |
| Forecast period | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Pre-commercial/ R&D Scale, Commercial Scale |
| Key market players worldwide | Miltenyi Biotec, Lonza Group Ltd, Fresenius SE & Co KGaA, Cytiva, Terumo Corp, Sartorius AG, ThermoGenesis Holdings Inc, Thermo Fisher Scientific Inc, Biospherix, Cellares |
Other key industry trends
- In terms of revenue, U.S. accounted for 46.3% of the global automated and closed cell therapy processing systems market in 2024.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In North America, U.S. automated and closed cell therapy processing systems market is projected to lead the regional market in terms of revenue in 2030.
- U.S. is the fastest growing regional market in North America and is projected to reach USD 1,876.7 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Automated and Closed Cell Therapy Processing Systems Market Scope
Automated and Closed Cell Therapy Processing Systems Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
U.S. automated and closed cell therapy processing systems market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to automated and closed cell therapy processing systems market will help companies and investors design strategic landscapes.
Pre-commercial/ r&d scale was the largest segment with a revenue share of 88.78% in 2024. Horizon Databook has segmented the U.S. automated and closed cell therapy processing systems market based on pre-commercial/ r&d scale, commercial scale covering the revenue growth of each sub-segment from 2018 to 2030.
Reasons to subscribe to U.S. automated and closed cell therapy processing systems market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of U.S. automated and closed cell therapy processing systems market databook
-
Our clientele includes a mix of automated and closed cell therapy processing systems market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. automated and closed cell therapy processing systems market , including forecasts for subscribers. This country databook contains high-level insights into U.S. automated and closed cell therapy processing systems market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
U.S. automated closed cell therapy processing systems market report size, by workflow, 2018-2030 (US$M)
U.S. Automated and Closed Cell Therapy Processing Systems Market Outlook Share, 2024 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
